Assignee
CANCER RES CAMPAIGN TECH
GB·53 granted patents·1 pending application·1,818 citations·filing 1989–2004
Top patents by PatentIndex Score
54 records- 0197US6130237ACondensed N-aclyindoles as antitumor agentsCANCER RES CAMPAIGN TECH·Filed 1999·Granted Oct 10, 2000·146 cites·18 claims
- 0295US5811454A4-amino-fluorobenzamides and their use as cytotoxic prodrugsCANCER RES CAMPAIGN TECH·Filed 1994·Granted Sep 22, 1998·58 cites·13 claims
- 0393US5728868AProdrugs of protein tyrosine kinase inhibitorsCANCER RES CAMPAIGN TECH·Filed 1994·Granted Mar 17, 1998·119 cites·3 claims
- 0493US5457130AEicosapentaenoic acid used to treat cachexiaCANCER RES CAMPAIGN TECH·Filed 1994·Granted Oct 10, 1995·191 cites·4 claims
- 0592US5281620ACompounds having antitumor and antibacterial propertiesCANCER RES CAMPAIGN TECH·Filed 1992·Granted Jan 25, 1994·48 cites·6 claims
- 0691US6303323B1Detection of dysplastic or neoplastic cells using anti-MCM5 antibodiesCANCER RES CAMPAIGN TECH·Filed 1998·Granted Oct 16, 2001·81 cites·21 claims
- 0790US7083983B2Inhibitors of the interaction between P53 and MDM2CANCER RES CAMPAIGN TECH·Filed 1997·Granted Aug 1, 2006·108 cites·15 claims
- 0888US5260291ATetrazine derivativesCANCER RES CAMPAIGN TECH·Filed 1991·Granted Nov 9, 1993·135 cites·33 claims
- 0984US6977298B2Tricyclic inhibitors of poly(ADP-ribose) polymerasesCANCER RES CAMPAIGN TECH·Filed 2004·Granted Dec 20, 2005·16 cites·8 claims
- 1083US5929046APyrimidine and purine derivatives and their use in treating tumour cellsCANCER RES CAMPAIGN TECH·Filed 1995·Granted Jul 27, 1999·38 cites·19 claims
- 1183US5716990ADrug delivery systemsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Feb 10, 1998·64 cites·6 claims
- 1281US6531097B1Measuring the concentration of a substanceCANCER RES CAMPAIGN TECH·Filed 2000·Granted Mar 11, 2003·34 cites·32 claims
- 1380US6303618B1Cyclin dependent kinase inhibiting purine derivativesCANCER RES CAMPAIGN TECH·Filed 2000·Granted Oct 16, 2001·17 cites·15 claims
- 1480US5876691AAntibody against carcionembryonic antigen (CEA)CANCER RES CAMPAIGN TECH·Filed 1994·Granted Mar 2, 1999·77 cites·23 claims
- 1580US5633158ABacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic formCANCER RES CAMPAIGN TECH·Filed 1992·Granted May 27, 1997·25 cites·13 claims
- 1679US5869053A5T4 antigen from human trophoblastsCANCER RES CAMPAIGN TECH·Filed 1993·Granted Feb 9, 1999·64 cites·13 claims
- 1778US6165715AExpression systemsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Dec 26, 2000·50 cites·35 claims
- 1875US5977065ABacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic formCANCER RES CAMPAIGN TECH·Filed 1998·Granted Nov 2, 1999·16 cites·11 claims
- 1974US6043228AO6 -substituted guanine derivatives, a process for their preparation and their use in treating tumor cellsCANCER RES CAMPAIGN TECH·Filed 1995·Granted Mar 28, 2000·26 cites·35 claims
- 2074US5780585ABacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic formCANCER RES CAMPAIGN TECH·Filed 1995·Granted Jul 14, 1998·30 cites·8 claims
- 2173US5750782ANitroaniline derivatives and their use as anti-tumour agentsCANCER RES CAMPAIGN TECH·Filed 1996·Granted May 12, 1998·13 cites·4 claims
- 2272US6251933B1Seco precursors of cyclopropylindolines and their use as prodrugsCANCER RES CAMPAIGN TECH·Filed 1997·Granted Jun 26, 2001·17 cites·14 claims
- 2371US5958721AMethods for screening of substances for therapeutic activity and yeast for use thereinCANCER RES CAMPAIGN TECH·Filed 1994·Granted Sep 28, 1999·17 cites·39 claims
- 2470US6852755B1Nitrogen mustard compounds and prodrugs thereforCANCER RES CAMPAIGN TECH·Filed 2000·Granted Feb 8, 2005·4 cites·52 claims
- 2570US6066457AGlobal amplification of nucleic acidsCANCER RES CAMPAIGN TECH·Filed 1998·Granted May 23, 2000·31 cites·28 claims
- 2670US5843143ALight sourceCANCER RES CAMPAIGN TECH·Filed 1993·Granted Dec 1, 1998·101 cites·26 claims
- 2769US6005002ANitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their productionCANCER RES CAMPAIGN TECH·Filed 1996·Granted Dec 21, 1999·29 cites·10 claims
- 2869US5985909ACyclopropylindoles and their seco precursors, and their use as prodrugsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Nov 16, 1999·14 cites·12 claims
- 2964US6034246A2-arylbenzazole compoundsCANCER RES CAMPAIGN TECH·Filed 1997·Granted Mar 7, 2000·29 cites·24 claims
- 3063US6020309APharmaceuticals based on papillomavirusesCANCER RES CAMPAIGN TECH·Filed 1994·Granted Feb 1, 2000·20 cites·7 claims
- 3161US6677345B1Cyclin dependent kinase inhibitorsCANCER RES CAMPAIGN TECH·Filed 2000·Granted Jan 13, 2004·1 cites·28 claims
- 3261US5385740ABiologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereofCANCER RES CAMPAIGN TECH·Filed 1992·Granted Jan 31, 1995·15 cites·3 claims
- 3360US5854244AMelamine derivatives for use in the treatment of cancerCANCER RES CAMPAIGN TECH·Filed 1996·Granted Dec 29, 1998·8 cites·8 claims
- 3459US5731304APotentiation of temozolomide in human tumour cellsCANCER RES CAMPAIGN TECH·Filed 1994·Granted Mar 24, 1998·30 cites·11 claims
- 3558US5571845ANitroaniline derivatives and their use as anti-tumour agentsCANCER RES CAMPAIGN TECH·Filed 1992·Granted Nov 5, 1996·6 cites·9 claims
- 3657US6174532B1L2 immunogenic peptides of papillomavirusCANCER RES CAMPAIGN TECH·Filed 1995·Granted Jan 16, 2001·22 cites·21 claims
- 3757US6096724APyrimidine derivatives and guanine derivatives, and their use in treating tumor cellsCANCER RES CAMPAIGN TECH·Filed 1998·Granted Aug 1, 2000·16 cites·34 claims
- 3855US6380157B1Method of treatment using papillomavirus L2 proteinCANCER RES CAMPAIGN TECH·Filed 1995·Granted Apr 30, 2002·8 cites·13 claims
- 3955US5874431ABenzazole compoundsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Feb 23, 1999·27 cites·24 claims
- 4053US5219579ABiologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereofCANCER RES CAMPAIGN TECH·Filed 1989·Granted Jun 15, 1993·17 cites·9 claims
- 4152US2002136736A1Papillomavirus L2 proteinCANCER RES CAMPAIGN TECH·Filed 2002·Application pending·0 cites
- 4244US6004550AIntracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug systemCANCER RES CAMPAIGN TECH·Filed 1995·Granted Dec 21, 1999·3 cites·10 claims
- 4343US6124310AEnediyne compoundsCANCER RES CAMPAIGN TECH·Filed 1996·Granted Sep 26, 2000·13 cites·24 claims
- 4438US7018791B1Binding complexesCANCER RES CAMPAIGN TECH·Filed 1998·Granted Mar 28, 2006·6 cites·18 claims
- 4538US6025340ASurface expression of enzyme in gene directed prodrug therapyCANCER RES CAMPAIGN TECH·Filed 1995·Granted Feb 15, 2000·2 cites·23 claims
- 4638US5373092ADerivatives of hydroxymethoxy mandelic acid (HMMA), homovanillic acid (HVA), antibodies and labelled substances prepared therefrom, and immunoassays using theseCANCER RES CAMPAIGN TECH·Filed 1993·Granted Dec 13, 1994·9 cites·12 claims
- 4738US5266720ADerivatives of hydroxymethoxy mandelic acid (HMMA), homovanillic acid (HVA), antibodies and labelled substances prepared therefrom, and immunoassays using theseCANCER RES CAMPAIGN TECH·Filed 1990·Granted Nov 30, 1993·9 cites·4 claims
- 4836US6255070B1Folding protein complexesCANCER RES CAMPAIGN TECH·Filed 1995·Granted Jul 3, 2001·2 cites·50 claims
- 4933US5958682ABacterial nitroreductase gene-prodrug systemCANCER RES CAMPAIGN TECH·Filed 1994·Granted Sep 28, 1999·1 cites·14 claims
- 5031US5359120AImprovements relating to the production of prodrugsCANCER RES CAMPAIGN TECH·Filed 1989·Granted Oct 25, 1994·0 cites·9 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →